Qianqian Yin, PhD (she/her/hers)

Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Shanghai, Shanghai, China

translational science research in pharmaceutical R&D department

Presentation(s):

• 0998: Preclinical Characterization of a Novel Bi-specific Antibody Targeting IL-23p19 and IL-36R for The Treatment of Autoimmune Diseases

  Monday, October 27, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure(s): No financial relationships with ineligible companies to disclose